@BioChemAdda | BioTech Adda -  No. 1 #Jobs, #Events, & #News Portal. #Biotech Jobs, Biotech #Vacancy, Biotech #Naukri, #Chemistry Jobs, #Biosciences #Careers.

Joined November 2009
2,664 Photos and videos
Future proof your biotech career with the required skills - Admissions Open - Biocon KGI Certificate Program in Biosciences - mailchi.mp/890157e5706b/admi…
3
Learn the applied knowledge on various Good Regulatory Practices (GRA) - Admissions Open for Certificate Program in GRA - mailchi.mp/a28d0700fa8e/admi…
1
Biocon Ramaiah Certificate Program in QC Analytical, Batch 3 - mailchi.mp/c2aaa68146a9/appl… Please mention @BioChemAdda while applying to this program. admission.bioconacademy.com/…)

$AUTL - Autolus Announces Proposed Public Offering in the United States autolus.gcs-web.com/news-rel…

$CSII - First Patient in Europe Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System investors.csi360.com/news-re…

$NAVB - Navidea Biopharmaceuticals Announces Submission of Formal Type B Meeting Request with FDA and Launch of NAV3-32 Phase 2B Trial in Rheumatoid Arthritis navidea.com/news-media/press…
$RVMD - Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares benzinga.com/pressreleases/2…

$IRWD - Ironwood Pharmaceuticals Announces CEO Transition benzinga.com/pressreleases/2…

1
$ENTA - Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET benzinga.com/pressreleases/2…

$BXRX - Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules benzinga.com/pressreleases/2…

$SRNE - Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic - manufacture of antibody-drug conjugates (ADC)
1
2
4
$FOLD - Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021
$FOLD - Amicus announces early-stage interim data for AT-GTX-502 in Batten disease seekingalpha.com/news/365964…
#biowar $SRNE Prospects Look Bright. Several COVID-19 therapeutics plus diagnostic tests.
3
Hey @WSBChairman... please suggest... $srne is it worth (to the moon). Currently in $12-13 range. But few analysts project it to be worth of $35.
BioChem Adda retweeted
7 Apr 2020
A recent study coming from #France found no evidence of a strong antiviral activity or clinical benefit of the combination of #hydroxychloroquine and #azithromycin for the treatment of hospitalized patients with severe #COVID19 #coronavirus #COVID sciencedirect.com/science/ar…

1
4
3